Log In
BCIQ
Print this Print this
 

LY3202328

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionUndisclosed oral therapeutic
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDyslipidemia
Indication DetailsTreat dyslipidemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today